Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Dosage Form Design Considerations: Volume I
    Unavailable
    Dosage Form Design Considerations: Volume I
    Unavailable
    Dosage Form Design Considerations: Volume I
    Ebook1,962 pages23 hours

    Dosage Form Design Considerations: Volume I

    By Academic Press

    2/5

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Dosage Form Design Parameters, Volume I, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism. Written by experts in the field, this volume in the Advances in Pharmaceutical Product Development and Research series deepens our understanding of dosage form design parameters. Chapters delve into a particular aspect of this fundamental field, covering principles, methodologies and the technologies employed by pharmaceutical scientists. In addition, the book contains a comprehensive examination suitable for researchers and advanced students working in pharmaceuticals, cosmetics, biotechnology and related industries.

    • Examines the history and recent developments in drug dosage forms for pharmaceutical sciences
    • Focuses on physicochemical aspects, prefomulation solid state properties and polymorphism
    • Contains extensive references for further discovery and learning that are appropriate for advanced undergraduates, graduate students and those interested in drug dosage design
    LanguageEnglish
    PublisherAcademic Press
    Release dateJul 28, 2018
    ISBN9780128144244
    Unavailable
    Dosage Form Design Considerations: Volume I

    Related to Dosage Form Design Considerations

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Opinion: Improving The Next Generation Of Drugs Through Patient-centric Design For Clinical Trials

      Dec 26, 2019

      In developing cancer drugs, the focus has been on eradicating cancer cells and shrinking tumors. It's time to also focus on patient factors like tolerability, ease of use, compliance with…

      3 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Restricting Drug Reps May Shift Doctors to Generics

      May 3, 2017

      A new study suggests that restricting how pharmaceutical sales representatives can market drugs to physicians changes which medications doctors prescribe to their patients. A team of researchers examined restrictions at 19 academic medical centers (A

      2 min read

    • Article

      References

      Mar 5, 2023

      HOW BETTER SLEEP CAN HELP WITH A HEALTHY WEIGHT, p28 Health Navigator. Common Sleep Problems. Available at www. healthnavigator.org.nz Accessed February 2023. Katsunuma et.al. 2017. Unrecognized Sleep Loss Accumulated in Daily Life Can Promote Brain

      2 min read

    • Article

      When Will Your Insulin Be Generic?

      Apr 12, 2019

      When Will Your Insulin Be Generic?
      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Needed: An FDA Revolution

      May 2, 2018

      Needed: An FDA Revolution
      2 min read

    • Article

      Altering Gut Bacteria Can Shield Liver From Medicine

      Sep 19, 2017

      Modulating gut bacteria could enhance the therapeutic value of a drug, research with the Alzheimer’s medication tacrine suggests. Enzymes in the liver break down pharmaceutical drugs into their metabolites, which the body then excretes in feces and u

      2 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      Opinion: Games And Greed Delay The Market Entry Of Money-saving Biosimilars

      May 9, 2018

      Schemes to prolong monopoly profits of brand-name drugs are to blame for the slow market entry of biosimilars.

      2 min read

    • Article

      Probiotics Are Touted As Good For The Gut. They May Be Trouble For The Immune System

      Apr 2, 2019

      Some scientists worry probiotics aren’t as innocuous as they seem — and might be affecting the way other medicines work in the body.

      4 min read

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      Opinion: The Breakthrough Therapy Designation For Promising Cancer Drugs Is Good For Patients

      Apr 27, 2018

      The breakthrough therapy designation is an essential FDA program intended to speed access to lifesaving drugs for the patients who need them most.

      3 min read

    • Article

      Opinion: U.S. Biologics And Biosimilars Need Distinguishable Names

      Apr 23, 2019

      Creating distinguishable nonproprietary names for biologics and their biosimilars will help ensure that patients get the right medications and will be useful for identifying adverse events more readily.

      5 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    Reviews for Dosage Form Design Considerations

    2/5

    1 rating0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words